Jiangsu Vcare Pharmaceutical Technology Co., Ltd
Clinical trials sponsored by Jiangsu Vcare Pharmaceutical Technology Co., Ltd, explained in plain language.
-
New eczema cream shows promise in early trial
Symptom relief CompletedThis study tested a cream called VC005 in 118 adults with mild to moderate atopic dermatitis (eczema). The goal was to see if it reduces skin redness, itching, and rash better than a cream with no active ingredient. Researchers measured changes in the Eczema Area and Severity Ind…
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated May 17, 2026 11:52 UTC
-
New eczema drug tested in teens: safe or not?
Symptom relief CompletedThis early-stage study tested a new drug called VC005 in 11 teenagers aged 12-18 with mild to moderate atopic dermatitis (eczema). The main goal was to check safety and how the drug moves through the body. It was a small, open-label study with no comparison group, so it only give…
Phase: PHASE1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated May 06, 2026 16:03 UTC
-
Blood thinner showdown: new drug tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new blood thinner called vicagrel against the standard drug clopidogrel in 18 healthy adults who have a specific gene that helps process these medicines. The goal was to see how the body absorbs and responds to each drug. Results will help doctors understand i…
Phase: PHASE1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC